Literature DB >> 22023105

Unlicensed use of metformin in children and adolescents in Germany and France.

Karel Kostev, Hartmut Richter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22023105      PMCID: PMC3269590          DOI: 10.1111/j.1365-2125.2011.04099.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  3 in total

1.  Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial.

Authors:  Kenneth Lee Jones; Silva Arslanian; Valentina A Peterokova; Jong-Soon Park; Mark J Tomlinson
Journal:  Diabetes Care       Date:  2002-01       Impact factor: 19.112

2.  Validity and representativeness of the "Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies.

Authors:  H Becher; K Kostev; D Schröder-Bernhardi
Journal:  Int J Clin Pharmacol Ther       Date:  2009-10       Impact factor: 1.366

3.  Unlicensed use of metformin in children and adolescents in the UK.

Authors:  Yingfen Hsia; Dalia Dawoud; Alastair G Sutcliffe; Russell M Viner; Sanjay Kinra; Ian C K Wong
Journal:  Br J Clin Pharmacol       Date:  2012-01       Impact factor: 4.335

  3 in total
  3 in total

1.  Long term trends in oral antidiabetic drug use among children and adolescents in the Netherlands.

Authors:  S Fazeli Farsani; P C Souverein; J A Overbeek; M M J van der Vorst; C A J Knibbe; R M C Herings; A de Boer; A K Mantel-Teeuwisse
Journal:  Br J Clin Pharmacol       Date:  2015-05-20       Impact factor: 4.335

2.  Metformin in the treatment of obese children and adolescents at risk of type 2 diabetes.

Authors:  Deborah L Kendall; Rakesh Amin; Peter E Clayton
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

3.  Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.

Authors:  M P van der Aa; M A J Elst; E M W van de Garde; E G A H van Mil; C A J Knibbe; M M J van der Vorst
Journal:  Nutr Diabetes       Date:  2016-08-29       Impact factor: 5.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.